Efficacy of Arjun (Terminalia arjuna (Roxb. ex DC.) Wight & Arn.) in Arterial Stiffness: A Case Report
Abstract
Arterial stiffness is a growing epidemic associated with an increased risk of cardiovascular events. Arteriosclerosis means hardening of the arteries. Arterial stiffness or arteriosclerosis is often associated with but is distinct from atherosclerosis. High arterial stiffness is known to be a risk factor, as well as a prognostic marker for cardiovascular disease. Terminalia arjuna (Roxb.) Wight & Arn., an indigenous medicinal plant, has been proven to possess different cardioprotective properties, including positive inotropic, hypolipidemic, coronary vasodilatory, and antioxidant effects. A 40-year-old male presented to the outpatient department of Ajmal Khan Tibbiya College and Hospital in August 2022. The patient was diagnosed case of hypertension and type 2 diabetes mellitus and was taking medicines for the same regularly. His vitals and general physical and systemic examination were within normal limits at the time of interrogation, and all his baseline investigations, except his lipid profile, were within normal limits. The patient was screened for arterial stiffness, for which cardiovascular profile tests were performed on the patient using Diabetes Risk Profiler for the assessment of arterial health analysis, which showed severe arterial stiffness. After 12 weeks of treatment with the decoction of powder of chāl arjun (bark of Terminalia arjuna) 6 g twice daily, arterial health analysis assessment improved to mild arterial stiffness. The probable reason for improvement could be due to the mufattiḥ sudad (deobstruent), muraqqiq-e-dam (blood thinner), and muqawwī-i-qalb (cardiotonic) action of chāl arjun. This case report emphasizes and highlights the effect of Terminalia arjuna on arterial stiffness.
Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005;25:932-943.
Cecelja M, Chowienczyk P. Role of arterial stiffness in cardiovascular disease. JRSM Cardiovasc Dis 2012;1:1-0.
Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology. 9th ed. Elsevier. 2013; pp 335-343.
Adebayo O, Adeoye AM. Atherosclerosis: a journey around the terminology. In Atherosclerosis, Arteriosclerosis and Arteriolosclerosis. 2020. Intech Open.
Mitchell GF, Powell JT. Arteriosclerosis: a primer for “in focus” reviews on arterial stiffness. Arterioscler Thromb Vasc Biol 2020;40:1025
Fernandes VR, Polak JF, Cheng S, Rosen BD, Carvalho B, et al. Arterial stiffness is associated with regional ventricular systolic and diastolic dysfunction: the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol 2008;28:194-201.
Gómez-Marcos MÁ, Recio-Rodríguez JI, Patino-Alonso MC, Agudo-Conde C, Gómez-Sánchez L, et al. Relationship between intima-media thickness of the common carotid artery and arterial stiffness in subjects with and without type 2 diabetes: a case-series report. Cardiovascular Diabetol 2011;10:1-8.
Jālīnūs. Jwam‘ Kitāb al-Nabḍ al-Ṣaghīr Jālīnūs. Zillur Rahman S, Translator. Ibn Sina Academy. Aligarh 2007; pp 68, 69, 72, 81.
Rāzī ABMIZ. Kitāb al -Ḥāwī. Vol. 17. CCRUM. New Delhi 2008; pp 27, 31.
Rāzī ABMIZ. Kitāb al-Manṣūrī. CCRUM. New Delhi 1991; pp 67,160, 455.
Rāzī ABMIZ. Kitāb al-Murshid. Taraqqi Urdu Bureau. 2000; p 79.
Al-Majūsī AIA. Kāmil al-Ṣanā‘a. Kantūrī GḤ, translator. Vol 1. Idara Kitabush shifa. New Delhi 2010; pp 37,38,497-499.
Ibn-Sīnā. Al-Qānūn. Kantūrī SGH, translator. Vol. 1. Idara Kitabush Shifa. New Delhi. pp 138, 141.
Thakur S, Kaurav H, Chaudhary G. Terminalia arjuna: a potential ayurvedic cardio tonic. Int J Res Appl Sci Biotechnol 2021;8:227-236.
Kapoor D, Vijayvergiya R, Dhawan V. Terminalia arjuna in coronary artery disease: ethnopharmacology, pre-clinical, clinical & safety evaluation. J Ethnopharmacol 2014;155:1029-1045.
India Biodiversity Portal. Terminalia arjuna (Roxb.) Wight & Arn. by SONU KUMAR on 20 April 2022 [Internet]. VNCIndia. 2022. Available from: https://indiabiodiversity.org/group/VNCIndia/observation/show/17181926
Global Biodiversity Information Facility. Occurrence Detail 4510069606 [Internet]. Gbif.org. 2024 [cited 2024 Aug 20]. Available from: https://www.gbif.org/occurrence/4510069606
Global Biodiversity Information Facility. Occurrence Detail 4600159084 [Internet]. Gbif.org. 2024 [cited 2024 Aug 20]. Available from: https://www.gbif.org/occurrence/4600159084
K Maulik S, K Katiyar C. Terminalia arjuna in cardiovascular diseases: making the transition from traditional to modern medicine in India. Curr Pharm Biotechnol 2010;11:855-860.
PubChem. Arjunolic acid [Internet]. Nih.gov. PubChem; 2024 [cited 2024 Aug 20]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/73641#section=2D-Structure
PubChem. Arjugenin [Internet]. Nih.gov. PubChem; 2024 [cited 2024 Aug 20]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/12444386#section=2D-Structure
PubChem. Arjunic acid [Internet]. Nih.gov. PubChem; 2024 [cited 2024 Aug 20]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/15385516#section=2D-Structure
Amalraj A, Gopi S. Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: a review. J Tradit Complement Med 2017;7:65-78.
Bharani A, Ganguly A, Bhargava KD. Salutary effect of Terminalia arjuna in patients with severe refractory heart failure. Int J Cardiol 1995;49:191-9.
Kapoor D, Trikha D, Vijayvergiya R, Parashar KK, Kaul D, et al. Short-term adjuvant therapy with Terminalia arjuna attenuates ongoing inflammation and immune imbalance in patients with stable coronary artery disease: in vitro and in vivo evidence. J Cardiovasc Transl Res 2015;8:173-186.
Priya N, Mathur KC, Sharma A, Agrawal RP, Agarwal V, et al. Effect of Terminalia Arjuna on total platelet count and lipid profile in patients of coronary artery disease. Adv Hum Biol 2019;9:98-101.
The Unani Pharmacopoeia of India. Part 1, Vol. 4. New Delhi: Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Ministry of Health & Family Welfare, Government of India; 2008. pp. 13,14.
Khān MA. Muḥīṭ-i-A‘ẓam. Vol 3. CCRUM New Delhi 2014; p 271.
Prenner SB, Chirinos JA. Arterial stiffness in diabetes mellitus. Atherosclerosis 2015;238:370-379.
Aroor AR, Jia G, Sowers JR. Cellular mechanisms underlying obesity-induced arterial stiffness. Am J Physiol Regul Integr Comp Physiol 2018;314:R387-R398.
Nuamchit T, Siriwittayawan D, Thitiwuthikiat P. The relationship between glycemic control and concomitant Hypertension on arterial stiffness in type II diabetes. Vasc Health Risk Manag 2020;16:343-352.
Csige I, Ujvárosy D, Szabó Z, Lőrincz I, Paragh G, et al. The impact of obesity on the cardiovascular system. J Diabetes Res 2018;2018:3407306.
Reis JP, Allen NB, Bancks MP, Carr JJ, Lewis CE, et al. Duration of diabetes and prediabetes during adulthood and subclinical atherosclerosis and cardiac dysfunction in middle age: the CARDIA study. Diabetes Care 2018;41:731-738.
Nasir K, Cainzos-Achirica M, Valero-Elizondo J, Ali SS, Havistin R, et al. Coronary atherosclerosis in an asymptomatic US population: Miami heart study at Baptist Health South Florida. Cardiovasc Imaging 2022;15:1604-1618.
Dwivedi S, Agarwal MP. Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease. J Assoc Physicians India 1994;42:287-289.
Bhawani G, Kumar A, Murthy KS, Kumari N, Swami CG. A retrospective study of effect of Terminalia arjuna and evidence based standard therapy on echocardiographic parameters in patients of dilated cardiomyopathy. J Pharm Res 2013;6:493-498.
Sumitra M, Manikandan P, Kumar DA, Arutselvan N, Balakrishna K, et al. Experimental myocardial necrosis in rats: role of arjunolic acid on platelet aggregation, coagulation and antioxidant status. Mol Cell Biochem 2001;224:135-142.
Manna P, Sinha M, Sil PC. Phytomedicinal activity of Terminalia arjuna against carbon tetrachloride induced cardiac oxidative stress. Pathophysiology 2007;14:71-78.
Pawar RS, Bhutani KK. Effect of oleanane triterpenoids from Terminalia arjuna—a cardioprotective drug on the process of respiratory oxyburst. Phytomedicine 2005;12:391-393.
Gupta R, Singhal S, Goyle A, Sharma VN. Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomised placebo-controlled trial. J Assoc Physicians India 2001;49:231-235.
Subramaniam S, Subramaniam R, Rajapandian S, Uthrapathi S, Gnanamanickam VR, et al. Anti‐atherogenic activity of ethanolic fraction of terminalia arjuna bark on hypercholesterolemic rabbits. J Evid Based Complementary Altern Med 2011;2011:487916.
Issue | Vol 10, No 1, 2025 -In Press- | |
Section | Case Studies | |
Keywords | ||
Arterial stiffness Diabetes Risk Profiler Terminalia arjuna Unani medicine Case report |
Rights and permissions | |
![]() |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |